Tris

Mar 04, 2020

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates

Nov 07, 2019

Tris Pharma to Present Two Posters for Amphetamine Extended-Release Tablet at the 2019 Neuroscience Education Institute (NEI) Congress

Oct 30, 2019

Tris Pharma Adds Seasoned Attorney to its Senior Leadership Team

Aug 14, 2019

Tris Pharma Chief Medical Officer Elected to the American Psychiatric Association Assembly Executive Committee

Apr 30, 2019

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance

Mar 15, 2019

TRIS and LYCOS CHAT Announce Integration Partnership At SXSW

Dec 05, 2018

Tris Pharma Issues Voluntary Nationwide Recall of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Oct 10, 2018

Tris Pharma Announces Hiring of Chief Commercial Officer

Aug 27, 2018

Tris Pharma Announces Hiring of New Vice President of Quality & Compliance